During the last 30 years, deep brain stimulation (DBS) has evolved into the clinical standard
of care as a highly effective treatment for advanced Parkinson's disease. Careful patient …

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidum internus
(GPi) improves motor functions in patients with Parkinson's disease (PD) but may cause a …

Although deep brain stimulation (DBS) of the globus pallidus internus (GPi) and the
subthalamic nucleus (STN) has become an established treatment for Parkinson's disease …

Early involvement of gut is observed in Parkinson's disease (PD) and symptoms such as
constipation may precede motor symptoms. α-Synuclein pathology is extensively evident in …

Objective No definitive comparative studies of the efficacy of 'awake'deep brain stimulation
(DBS) for Parkinson's disease (PD) under local or general anaesthesia exist, and there …

Deep brain stimulation has already revolutionised the clinical management of treatment-
resistant movement disorders and offers novel treatment options for an increasing range of …

OBJECTIVE Deep brain stimulation (DBS) is effective in the management of patients with
advanced Parkinson's disease (PD). While both the globus pallidus pars interna (GPi) and …

Objective To compare subthalamic nucleus (STN) deep brain stimulation (DBS) with globus
pallidus interna (GPi) DBS for tremor suppression in Parkinson disease (PD). Background …

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the
loss of neuronal dopamine production in the brain. Oral therapies primarily augment the …

Nonmotor manifestations in Parkinson's disease (PD) encompass a range of clinical
features, including neuropsychiatric problems, autonomic dysfunction, sleep disorders …